Abstract
Synergistic interactions between viral proteins and soluble host factors released from infected mononuclear phagocytes play a critical role in the pathogenesis of human immunodeficiency virus (HIV)-associated dementia (HAD). The chemokine CXCL10 has been found to be closely associated with the progression of HIV-1-related central nervous system (CNS) disease and its related neuropsychiatric impairment. In this report the authors demonstrate that the HIV-1 protein Tat can interact with the proinflammatory cytokine interferon (IFN)-γ to dramatically induce the expression of CXCL10 in macrophages. Synergistic induction of CXCL10 by both Tat and IFN-γ was susceptible to inhibition by the MEK1/2 inhibitor U0126 and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580. In addition, JAK/STAT pathway plays a major role in Tat/γ-mediated CXCL10 induction in macrophages because pre-treatment of stimulated macrophages with JAK inhibitor completely abrogated the synergistic induction of the chemokine. Functionality of the synergistically induced CXCL10 was further demonstrated by its chemotactic activity for peripheral blood lymphocytes. Taken together, these findings demonstrate that the cooperative interaction of Tat and IFN-γ results in enhanced chemokine expression, which in turn can amplify the inflammatory responses within the CNS of HAD patients by recruiting more lymphocytes in the brain.
Similar content being viewed by others
References
Adle-Biassette H, Chretien F, Wingertsmann L, Hery C, Ereau T, Scaravilli F, Tardieu M, Gray F (1999). Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 25: 123–133.
Asensio VC, Maier J, Milner R, Boztug K, Kincaid C, Moulard M, Phillipson C, Lindsley K, Krucker T, Fox HS, Campbell IL (2001). Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J Virol 75: 7067–7077.
Boehm U, Klamp T, Groot M, Howard JC (1997). Cellular responses to interferon-gamma. Annu Rev Immunol 15: 749–795.
Buch S, Pinson D, King CL, Raghavan R, Hou Y, Li Z, Adany I, Hicks A, Villinger F, Kumar A, Narayan O (2001). Inhibitory and enhancing effects of IFN-gamma and IL-4 on SHIV(KU) replication in rhesus macaque macrophages: correlation between Th2 cytokines and productive infection in tissue macrophages during late-stage infection. Cytokine 13: 295–304.
Budka H (1991). Neuropathology of human immunodeficiency virus infection. Brain Pathol 1: 163–175.
Darbinian-Sarkissian N, Czernik M, Peruzzi F, Gordon J, Rappaport J, Reiss K, Khalili K, Amini S (2006). Dysregulation of NGF-signaling and Egr-1 expression by Tat in neuronal cell culture. J Cell Physiol 208: 506–515.
D’Aversa TG, Yu KO, Berman JW (2004). Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. J NeuroVirol 10: 86–97.
Dhillon NK, Peng F, Ransohoff RM, Buch S (2007). PDGF synergistically enhances IFN-gamma-induced expression of CXCL10 in blood-derived macrophages: implications for HIV dementia. J Immunol 179: 2722–2730.
Fantuzzi L, Belardelli F, Gessani S (2003). Monocyte/ macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: a complex network of interactions influencing viral replication and AIDS pathogenesis. J Leukoc Biol 74: 719–725.
Fife BT, Kennedy KJ, Paniagua MC, Lukacs NW, Kunkel SL, Luster AD, Karpus WJ (2001). CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166: 7617–7624.
Flora G, Lee YW, Nath A, Hennig B, Maragos W, Toborek M (2003). Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain. Exp Neurol 179: 60–70.
Garden GA (2002). Microglia in human immunodeficiency virus-associated neurodegeneration. Glia 40: 240–251.
Ghafouri M, Amini S, Khalili K, Sawaya BE (2006). HIV-1 associated dementia: symptoms and causes. Retrovirology 3: 28.
Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995). Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755–762.
Glass JD, Wesselingh SL, Selnes OA, McArthur JC (1993). Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 43: 2230–2237.
Glass WG, Rosenberg HF, Murphy PM (2003). Chemokine regulation of inflammation during acute viral infection. Curr Opin Allergy Clin Immunol 3: 467–473.
Gray F, Adle-Biassette H, Brion F, Ereau T, le Maner I, Levy V, Corcket G (2000). Neuronal apoptosis in human immunodeficiency virus infection. J NeuroVirol 6(Suppl 1): S38-S43.
Griffin DE (1997). Cytokines in the brain during viral infection: clues to HIV-associated dementia. J Clin Invest 100: 2948–2951.
Hegg CC, Hu S, Peterson PK, Thayer SA (2000). Beta-chemokines and human immunodeficiency virus type-1 proteins evoke intracellular calcium increases in human microglia. Neuroscience 98: 191–199.
Kanda N, Watanabe S (2007). Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology 148: 2317–2325.
Kawano H, Kim S, Ohta K, Nakao T, Miyazaki H, Nakatani T, Iwao H (2003). Differential contribution of three mitogen-activated protein kinases to PDGF-BB-induced mesangial cell proliferation and gene expression. J Am Soc Nephrol 14: 584–592.
Kolb SA, Sporer B, Lahrtz F, Koedel U, Pfister HW, Fontana A (1999). Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. J Neuroimmunol 93: 172–181.
Kumar A, Dhawan S, Mukhopadhyay A, Aggarwal BB (1999). Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB. FEBS Lett 462: 140–144.
Lane BR, King SR, Bock PJ, Strieter RM, Coffey MJ, Markovitz DM (2003). The C-X-C chemokine IP-10 stimulates HIV-1 replication. Virology 307: 122–134.
Li X, Ponten A, Aase K, Karlsson L, Abramsson A, Uutela M, Backstrom G, Hellstrom M, Bostrom H, Li H, Soriano P, Betsholtz C, Heldin CH, Alitalo K, Ostman A, Eriksson U (2000). PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2: 302–309.
Maragos WF, Young KL, Turchan JT, Guseva M, Pauly JR, Nath A, Cass WA (2002). Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. J Neurochem 83: 955–963.
Muller WE, Schroder HC, Ushijima H, Dapper J, Bormann J (1992). gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. EurJ Pharmacol 226: 209–214.
Pellicelli AM, Palmieri F, Cicalini S, Petrosillo N (2001). Pathogenesis of HIV-related pulmonary hypertension. Ann N Y Acad Sci 946: 82–94.
Pistritto G, Ventura L, Mores N, Lacal PM, D’Onofrio C (1994). Regulation of PDGF-B and PDGF receptor expression in the pathogenesis of Kaposi’s sarcoma in AIDS. Antibiot Chemother 46: 73–87.
Poluektova L, Moran T, Zelivyanskaya M, Swindells S, Gendelman HE, Persidsky Y (2001). The regulation of alpha chemokines during HIV-1 infection and leukocyte activation: relevance for HIV-1-associated dementia. J Neuroimmunol 120: 112–128.
Potula R, Dhillion N, Sui Y, Zien CA, Funa K, Pinson D, Mayo MS, Singh DK, Narayan O, Buch S (2004). Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis. Am J Pathol 165: 815–824.
Raghavan R, Stephens EB, Joag SV, Adany I, Pinson DM, Li Z, Jia F, Sahni M, Wang C, Leung K, Foresman L, Narayan O (1997). Neuropathogenesis of chimeric simian/human immunodeficiency virus infection in pig-tailed and rhesus macaques. Brain Pathol 7: 851–861.
Rani MR, Ransohoff RM (2005). Alternative and accessory pathways in the regulation of IFN-beta-mediated gene expression. J Interferon Cytokine Res 25: 788–798.
Romashkova JA, Makarov SS (1999). NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401: 86–90.
Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC (2001). HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology 56: 257–260.
Sanders VJ, Pittman CA, White MG, Wang G, Wiley CA, Achim CL (1998). Chemokines and receptors in HIV encephalitis. AIDS 12: 1021–1026.
Sasseville VG, Smith MM, Mackay CR, Pauley DR, Mansfield KG, Ringler DJ, Lackner AA (1996). Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am J Pathol 149: 1459–1467.
Shapshak P, Duncan R, Minagar A, Rodriguez dlV, Stewart RV, Goodkin K (2004). Elevated expression of IFN-gamma in the HIV-1 infected brain. Front Biosci 9: 1073–1081.
Sorensen TL, Roed H, Sellebjerg F (2004). Optic neuritis: chemokine receptor CXCR3 and its ligands. Br J Ophthalmol 88: 1146–1148.
Sridhar P, Liu Y, Chin LD, Borja CE, Mann M, Skopicki HA, Freter RR (1999). Platelet-derived growth factor-stimulated expression of the MCP-1 immediate-early gene involves an inhibitory multiprotein complex. Mol Cell Biol 19: 4219–4230.
Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998). How cells respond to interferons. Annu Rev Biochem 67: 227–264.
Sui Y, Li S, Pinson D, Adany I, Li Z, Villinger F, Narayan O, Buch S (2005). Simian human immunodeficiency virus-associated pneumonia correlates with increased expression of MCP-1, CXCL10, and viral RNA in the lungs of rhesus macaques. Am J Pathol 166: 355–365.
Sui Y, Potula R, Dhillon N, Pinson D, Li S, Nath A, Anderson C, Turchan J, Kolson D, Narayan O, Buch S (2004). Neuronal apoptosis is mediated by CXCL10 over-expression in simian human immunodeficiency virus encephalitis. Am J Pathol 164: 1557–1566.
Sui Y, Potula R, Pinson D, Adany I, Li Z, Day J, Buch E, Segebrecht J, Villinger F, Liu Z, Huang M, Narayan O, Buch S (2003). Microarray analysis of cytokine and chemokine genes in the brains of macaques with SHIV-encephalitis. J Med Primatol 32: 229–239.
Sui Y, Stehno-Bittel L, Li S, Loganathan R, Dhillon NK, Pinson D, Nath A, Kolson D, Narayan O, Buch S (2006). CXCL10-induced cell death in neurons: role of calcium dysregulation. Eur J Neurosci 23: 957–964.
Toschi E, Bacigalupo I, Strippoli R, Chiozzini C, Cereseto A, Falchi M, Nappi F, Sgadari C, Barillari G, Mainiero F, Ensoli B (2006). HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway. Mol Biol Cell 17: 1985–1994.
Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, Tada K (1982). Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 42: 1530–1536.
Tyor WR, Wesselingh SL, Griffin JW, McArthur JC, Griffin DE (1995). Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr Hum Retrovirol 9: 379–388.
van Marle G, Henry S, Todoruk T, Sullivan A, Silva C, Rourke SB, Holden J, McArthur JC, Gill MJ, Power C (2004). Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology 329: 302–318.
Westendorp MO, Shatrov VA, Schulze-Osthoff K, Frank R, Kraft M, Los M, Krammer PH, Droge W, Lehmann V (1995). HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. EMBOJ 14: 546–554.
Westmoreland SV, Rottman JB, Williams KC, Lackner AA, Sasseville VG (1998). Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis. Am J Pathol 152: 659–665.
Wetzel MA, Steele AD, Henderson EE, Rogers TJ (2002). The effect of X4 and R5 HIV-1 on C, C-C, and C-X-C chemokines during the early stages of infection in human PBMCs. Virology 292: 6–15.
Yadav A, Kalita A, Dhillon S, Banerjee K (2005). JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3. J Biol Chem 280: 31830–31840.
Author information
Authors and Affiliations
Corresponding author
Additional information
Navneet Dhillon and Xuhui Zhu contributed equally to the study.
This work was supported by grants MH62969-01, RR016443, MH-068212, MH072355, and DA020392-01 from the National Institutes of Health and a fellowship from Parker B. Francis foundation.
An erratum to this article is available at http://dx.doi.org/10.1080/13550280902827067.
Rights and permissions
About this article
Cite this article
Dhillon, N., Zhu, X., Peng, F. et al. Molecular mechanism(s) involved in the synergistic induction of CXCL10 by human immunodeficiency virus type 1 Tat and interferon-γ in macrophages. Journal of NeuroVirology 14, 196–204 (2008). https://doi.org/10.1080/13550280801993648
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280801993648